5-(tetradecyloxy)-2-furancarboxylic acid has been researched along with 2-furoic acid in 1 studies
| Studies (5-(tetradecyloxy)-2-furancarboxylic acid) | Trials (5-(tetradecyloxy)-2-furancarboxylic acid) | Recent Studies (post-2010) (5-(tetradecyloxy)-2-furancarboxylic acid) | Studies (2-furoic acid) | Trials (2-furoic acid) | Recent Studies (post-2010) (2-furoic acid) |
|---|---|---|---|---|---|
| 51 | 0 | 16 | 67 | 0 | 42 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boonnate, P; Cha'on, U; Jitrapakdee, S; Kariya, R; Okada, S; Saranaruk, P; Sawanyawisuth, K; Vaeteewoottacharn, K | 1 |
1 other study(ies) available for 5-(tetradecyloxy)-2-furancarboxylic acid and 2-furoic acid
| Article | Year |
|---|---|
Five-(Tetradecyloxy)-2-furoic Acid Alleviates Cholangiocarcinoma Growth by Inhibition of Cell-cycle Progression and Induction of Apoptosis.
Topics: Acetyl-CoA Carboxylase; Apoptosis; Bile Duct Neoplasms; Biomarkers, Tumor; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Down-Regulation; Furans; Humans; Lipid Metabolism | 2021 |